# OnCo record karyopharm (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/karyopharm/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "karyopharm" ;
  schema:name "Karyopharm Therapeutics"@en ;
  schema:description "Karyopharm makes selinexor, the first nuclear export inhibitor, approved in myeloma; its endometrial cancer bet failed in 2026."@en ;
  schema:url <https://onco.cc/companies/karyopharm/>, <https://www.karyopharm.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.karyopharm.com> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/selinexor/> ;
  onco:trials <https://onco.cc/trials/nct04442022/>, <https://onco.cc/trials/nct02227251/>, <https://onco.cc/trials/nct02343042/>, <https://onco.cc/trials/nct04414475/>, <https://onco.cc/trials/nct04562389/> .